Alaska Permanent Fund

Total investments

19

Average round size

180M

Portfolio companies

11

Rounds per year

0.40

Lead investments

3

Follow on index

0.42

Exits

4

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsMedicalLife ScienceTherapeuticsAgTechGreenTechAgricultureFarming

Summary

Alaska Permanent Fund is the famous VC, which was founded in 1976. The main office of represented VC is situated in the Juneau. The company was established in North America in United States.

Opposing the other organizations, this Alaska Permanent Fund works on 7 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2017. The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from Alaska Permanent Fund is more than 1 billion dollars. The real fund results show that this VC is 2 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2017.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Alaska Permanent Fund, startups are often financed by Flagship Pioneering, ARCH Venture Partners, Fidelity Management and Research Company. The meaningful sponsors for the fund in investment in the same round are Flagship Pioneering, ARCH Venture Partners, Yukon Partners. In the next rounds fund is usually obtained by Flagship Pioneering, Baillie Gifford, Venrock.

We can highlight the next thriving fund investment areas, such as Therapeutics, IaaS. Among the most popular portfolio startups of the fund, we may highlight Juno Therapeutics, Indigo Agriculture, Denali Therapeutics. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 1 or 4 of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The overall number of key employees were 4.

Show more

Investments analytics

Analytics

Total investments
19
Lead investments
3
Exits
4
Rounds per year
0.40
Follow on index
0.42
Investments by industry
  • Biotechnology (11)
  • Therapeutics (8)
  • Medical (6)
  • Farming (5)
  • Agriculture (5)
  • Show 15 more
Investments by region
  • United States (19)
Peak activity year
2021
Number of Unicorns
3
Number of Decacorns
3
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
1B
Group Appearance index
0.89
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Codiak Biosciences 29 Nov 2017 Biotechnology, Medical, Therapeutics Late Stage Venture 76M United States, California, San Francisco
Romoni 07 Feb 2019 E-Commerce, Beauty, Fitness, Wellness, Women's Seed 60K Bangladesh, Dhaka Division, Dhaka
Ryne Biotechnology 29 Feb 2024 Biotechnology, Health Care, Medical Early Stage Venture 82M United States, Massachusetts, Cambridge
Siterra 25 Oct 2005 Software, Document Management Late Stage Venture 7M United States, California, San Francisco

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.